US Patent 11976130 Antibodies against claudin 18.2 useful in cancer diagnosis
Article
Patent abstract
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.